期刊文献+

壳聚糖温敏凝胶作为卡介苗载体在膀胱肿瘤治疗中的应用研究

Application of Chitosan Hydrogel as a Carrier of Bacillus Calmette-Guérin in the Treatment of Bladder Cancer
下载PDF
导出
摘要 目的研究卡介苗的磁性凝胶载体,用以进行膀胱灌注,延长卡介苗在膀胱内的滞留时间,并验证其在膀胱内的抗膀胱肿瘤作用。方法利用大鼠膀胱原位肿瘤动物模型,通过检测相关免疫学及肿瘤学指标评估其抗肿瘤效应。结果与普通卡介苗相比,同等剂量条件下使用卡介苗的磁性凝胶载体可较普通卡介苗在膀胱内产生更多的免疫细胞因子,在膀胱黏膜局部募集淋巴细胞浸润,诱导更强的免疫反应。经验证其抗膀胱肿瘤诱导效果优于普通卡介苗。结论壳聚糖温敏凝胶作为卡介苗载体,在磁场作用下增强了卡介苗的免疫活性及抗肿瘤效应,为卡介苗的应用提供了新的思路,有望成为用于膀胱癌术后灌注预防膀胱癌复发的更好的免疫制剂。 Objective In the former study,we developed a magnetic thermosensitive hydrogel as intravesical BCG delivery system,which was formulated with chitosan (CS),β-glycerophosphate (GP)and Fe3 O4 mag-netic nanoparticle (Fe3 O4 -MNP). The characteristics of the delivery system were determined and it could pro-long intravesical BCG residence time under an applied magnetic field. In this study,the antitumor effect and lo-cal immune activity of BCG loaded magnetic gel was evaluated. Methods The number and volume of tumors was recorded to identify the antitumor activity. Urinary cytokines analysis and immunohistochemistry study were ap-plied to determine the local immunity in bladder. Results In comparison to traditional BCG therapy for superfi-cial bladder tumor,BCG delivered by the gel system markedly increased the antitumor efficacy and induced a high local immunity in bladder. Conclusions The magnetic chitosan hydrogel developed in this work can increase the immunogenic potency of BCG and has great potential for use as a promising intravesical BCG delivery system for superficial bladder cancer.
出处 《泌尿外科杂志(电子版)》 2014年第1期5-12,共8页 Journal of Urology for Clinicians(Electronic Version)
关键词 卡介苗 膀胱灌注 壳聚糖 膀胱内药物释放 BCG,Intravesical instillation,Chitosan,Intravesical drug delivery
  • 相关文献

参考文献6

  • 1李云,许传亮,李志华,杨庆,顾正勤,王林辉,孙颖浩.两种构建大鼠膀胱癌模型方法的比较研究[J].临床泌尿外科杂志,2008,23(10):783-784. 被引量:11
  • 2Doron Amit,Ofer N. Gofrit,Imad Matouk,Tatiana Birman,Abraham Hochberg.Use of Preclinical Models to Assess the Therapeutic Potential of New Drug Candidates for Bladder Cancer[J].Seminars in Oncology.2012(5)
  • 3BelmiroParada,FlávioReis,ArnaldoFigueiredo,PedroNunes,EditeTeixeira‐Lemos,PatríciaGarrido,JoséSereno,RuiPinto,Maria F.X.Cunha,PaulaNeto,PauloSantos,IsabelVelada,AlfredoMota,FredericoTeixeira.Inhibition of bladder tumour growth by sirolimus in an experimental carcinogenesis model[J].BJU International.2010(1)
  • 4FABIEN SAINT,JEAN J. PATARD,PASCALE MAILLE,PASCALE SOYEUX,ANDRé HOZNEK,LAURENT SALOMON,CLAUDE C. ABBOU,DOMINIQUE K. CHOPIN.PROGNOSTIC VALUE OF A T HELPER 1 URINARY CYTOKINE RESPONSE AFTER INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT FOR SUPERFICIAL BLADDER CANCER[J].The Journal of Urology.2002(1)
  • 5Rolf J. Verheul,Maryam Amidi,Mies J. van Steenbergen,Elly van Riet,Wim Jiskoot,Wim E. Hennink.Influence of the degree of acetylation on the enzymatic degradation and in vitro biological properties of trimethylated chitosans[J].Biomaterials.2009(18)
  • 6Q. Peng,X. Sun,T. Gong,C.-Y. Wu,T. Zhang,J. Tan,Z.-R. Zhang.Injectable and biodegradable thermosensitive hydrogels loaded with PHBHHx nanoparticles for the sustained and controlled release of insulin[J].Acta Biomaterialia.2013(2)

二级参考文献4

  • 1Grubbs C J, Lubet R A, Koki A T, et al. Celecoxib inhibits N-butyl-N-( 4-hydroxybutyl )-nitrosamine-in- duced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats[J].Cancer Res, 2000, 60(20): 5599-5602.
  • 2Takei S, Iseda T, Yokoyama M, et al. Inhibitory effect of clotrimazole on angiogenesis associated with bladder epithelium proliferation in rats[J]. Int J Urol, 2003,10(2) : 78-85.
  • 3Hicks R M, Wakefield J S, et al. Rapid induction of bladder cancer in rats with N-methyl-N-nitrosourea. Histology[J]. Chem Biot Interaet, 1972, 5 (2): 139 -152.
  • 4Yaman O, Ozdiler E, Sozen S, et al. Transmurally absorbed intravesical Chemotherapy with dimethylsulfoxide in an animal model[J]. Int J Urol,1999,6(2) : 87-92.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部